16-1202340-C-T

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS2

The NM_021098.3(CACNA1H):​c.1890C>T​(p.Pro630Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000819 in 1,574,132 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P630P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.000085 ( 0 hom., cov: 34)
Exomes 𝑓: 0.000082 ( 0 hom. )

Consequence

CACNA1H
NM_021098.3 synonymous

Scores

2

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -2.40

Publications

0 publications found
Variant links:
Genes affected
CACNA1H (HGNC:1395): (calcium voltage-gated channel subunit alpha1 H) This gene encodes a T-type member of the alpha-1 subunit family, a protein in the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into the cell upon membrane polarization and consist of a complex of alpha-1, alpha-2/delta, beta, and gamma subunits in a 1:1:1:1 ratio. The alpha-1 subunit has 24 transmembrane segments and forms the pore through which ions pass into the cell. There are multiple isoforms of each of the proteins in the complex, either encoded by different genes or the result of alternative splicing of transcripts. Alternate transcriptional splice variants, encoding different isoforms, have been characterized for the gene described here. Studies suggest certain mutations in this gene lead to childhood absence epilepsy (CAE). [provided by RefSeq, Jul 2008]
CACNA1H Gene-Disease associations (from GenCC):
  • hyperaldosteronism, familial, type IV
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • childhood absence epilepsy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • epilepsy, childhood absence, susceptibility to, 6
    Inheritance: AD Classification: LIMITED Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BP6
Variant 16-1202340-C-T is Benign according to our data. Variant chr16-1202340-C-T is described in ClinVar as Likely_benign. ClinVar VariationId is 460054.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.4 with no splicing effect.
BS2
High AC in GnomAd4 at 13 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1HNM_021098.3 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 35 ENST00000348261.11 NP_066921.2 O95180-1B3KQH9

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1HENST00000348261.11 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 35 1 NM_021098.3 ENSP00000334198.7 O95180-1
CACNA1HENST00000569107.6 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 34 1 ENSP00000454990.2 H3BNT0
CACNA1HENST00000711493.1 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 34 ENSP00000518778.1
CACNA1HENST00000565831.7 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 34 1 ENSP00000455840.1 O95180-2
CACNA1HENST00000711450.1 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 35 ENSP00000518762.1
CACNA1HENST00000564231.6 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 35 1 ENSP00000457555.2 H3BUA8
CACNA1HENST00000638323.1 linkc.1851C>T p.Pro617Pro synonymous_variant Exon 9 of 35 5 ENSP00000492267.1 A0A1W2PR14
CACNA1HENST00000562079.6 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 34 1 ENSP00000454581.2 H3BMW6
CACNA1HENST00000711438.1 linkc.1851C>T p.Pro617Pro synonymous_variant Exon 9 of 34 ENSP00000518754.1
CACNA1HENST00000711482.1 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 36 ENSP00000518771.1
CACNA1HENST00000711485.1 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 35 ENSP00000518774.1
CACNA1HENST00000711455.1 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 36 ENSP00000518768.1
CACNA1HENST00000711483.1 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 35 ENSP00000518772.1
CACNA1HENST00000711456.1 linkc.1890C>T p.Pro630Pro synonymous_variant Exon 9 of 34 ENSP00000518769.1
CACNA1HENST00000621827.2 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 37 6 ENSP00000518766.1
CACNA1HENST00000637236.3 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 34 5 ENSP00000492650.2 A0A1W2PS38
CACNA1HENST00000639478.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 35 5 ENSP00000491945.1 A0A1W2PQW2
CACNA1HENST00000711442.1 linkn.*1337C>T non_coding_transcript_exon_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000711448.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518760.1
CACNA1HENST00000711449.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518761.1
CACNA1HENST00000711451.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518763.1
CACNA1HENST00000711452.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518764.1
CACNA1HENST00000711453.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518765.1
CACNA1HENST00000711484.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518773.1
CACNA1HENST00000711486.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 37 ENSP00000518775.1
CACNA1HENST00000711487.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 36 ENSP00000518776.1
CACNA1HENST00000711488.1 linkn.1890C>T non_coding_transcript_exon_variant Exon 9 of 35 ENSP00000518777.1
CACNA1HENST00000711442.1 linkn.*1337C>T 3_prime_UTR_variant Exon 8 of 34 ENSP00000518758.1
CACNA1HENST00000640028.1 linkn.1385+505C>T intron_variant Intron 9 of 34 5 ENSP00000491488.1 A0A1W2PQ19

Frequencies

GnomAD3 genomes
AF:
0.0000854
AC:
13
AN:
152204
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000337
AC:
6
AN:
178234
AF XY:
0.0000308
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000362
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000528
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000816
AC:
116
AN:
1421928
Hom.:
0
Cov.:
57
AF XY:
0.0000824
AC XY:
58
AN XY:
703870
show subpopulations
African (AFR)
AF:
0.0000922
AC:
3
AN:
32546
American (AMR)
AF:
0.0000511
AC:
2
AN:
39110
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25402
East Asian (EAS)
AF:
0.00
AC:
0
AN:
37188
South Asian (SAS)
AF:
0.0000743
AC:
6
AN:
80762
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48070
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5726
European-Non Finnish (NFE)
AF:
0.0000941
AC:
103
AN:
1094160
Other (OTH)
AF:
0.0000339
AC:
2
AN:
58964
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
8
16
24
32
40
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000854
AC:
13
AN:
152204
Hom.:
0
Cov.:
34
AF XY:
0.0000941
AC XY:
7
AN XY:
74356
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41460
American (AMR)
AF:
0.000131
AC:
2
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10628
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000147
AC:
10
AN:
68026
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.540
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000113
Hom.:
0
Bravo
AF:
0.0000945

ClinVar

Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Epilepsy, childhood absence, susceptibility to, 6;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Apr 14, 2022
Fulgent Genetics, Fulgent Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Idiopathic generalized epilepsy;C4310756:Hyperaldosteronism, familial, type IV Benign:1
Mar 06, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
0.66
DANN
Benign
0.67
PhyloP100
-2.4

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs755382298; hg19: chr16-1252340; API